- Home
- JMM vs VRCA Comparison
JMM vs VRCA Comparison
Compare JMM & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- VRCA
- Stock Information
- Founded
- JMM 1988
- VRCA 2013
- Country
- JMM United States
- VRCA United States
- Employees
- JMM N/A
- VRCA N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- JMM Finance
- VRCA Health Care
- Exchange
- JMM Nasdaq
- VRCA Nasdaq
- Market Cap
- JMM 58.5M
- VRCA 54.0M
- IPO Year
- JMM N/A
- VRCA 2018
- Fundamental
- Price
- JMM $6.19
- VRCA $0.58
- Analyst Decision
- JMM
- VRCA Hold
- Analyst Count
- JMM 0
- VRCA 5
- Target Price
- JMM N/A
- VRCA $6.00
- AVG Volume (30 Days)
- JMM 16.1K
- VRCA 254.0K
- Earning Date
- JMM 01-01-0001
- VRCA 08-13-2025
- Dividend Yield
- JMM 5.44%
- VRCA N/A
- EPS Growth
- JMM N/A
- VRCA N/A
- EPS
- JMM N/A
- VRCA N/A
- Revenue
- JMM N/A
- VRCA $7,179,000.00
- Revenue This Year
- JMM N/A
- VRCA $171.87
- Revenue Next Year
- JMM N/A
- VRCA $71.38
- P/E Ratio
- JMM N/A
- VRCA N/A
- Revenue Growth
- JMM N/A
- VRCA N/A
- 52 Week Low
- JMM $5.29
- VRCA $0.38
- 52 Week High
- JMM $6.10
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- JMM 50.23
- VRCA 49.82
- Support Level
- JMM $6.06
- VRCA $0.60
- Resistance Level
- JMM $6.27
- VRCA $0.71
- Average True Range (ATR)
- JMM 0.09
- VRCA 0.07
- MACD
- JMM -0.01
- VRCA -0.00
- Stochastic Oscillator
- JMM 54.55
- VRCA 43.69
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.